Trial Profile
Planned phase I trial investigating TKM ALDH2 in healthy volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2013
Price :
$35
*
At a glance
- Drugs TKM ALDH2 (Primary)
- Indications Alcoholism
- Focus Adverse reactions
- Sponsors Arbutus Biopharma
- 16 Oct 2013 New trial record
- 08 Oct 2013 An IND for TKM ALDH2 is expected to be filed in the second half of 2014, with phase I data available in 2015, according to a Tekmira Pharmaceuticals Corporation media release.